Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

575 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical outcomes of early WT1 mRNA reduction after remission induction in newly diagnosed acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation.
Tsushima T, Kimeda C, Yoda N, Matsuo K, Tanaka K, Hatanaka Y, Matsumoto R, Shimoji S, Utsu Y, Masuda SI, Aotsuka N. Tsushima T, et al. Transplant Cell Ther. 2024 Dec 16:S2666-6367(24)00807-8. doi: 10.1016/j.jtct.2024.12.007. Online ahead of print. Transplant Cell Ther. 2024. PMID: 39694194 Free article.
Phase 1b/2 study of the liposomal formulation of eribulin (E7389-LF) in combination with nivolumab: Results from the phase 2 esophageal cancer cohort.
Oshima T, Yamamoto S, Kawakami H, Makino T, Kawazoe A, Masuishi T, Tsushima T, Hirao M, Tsuda M, Hino K, Yamamoto N, Hara H, Kaname S, Matsuoka D, Otake Y, Yasuda K, Takase T, Takashima S, Semba T, Ooki A. Oshima T, et al. Among authors: tsushima t. BJC Rep. 2024 Sep 4;2(1):66. doi: 10.1038/s44276-024-00066-6. BJC Rep. 2024. PMID: 39516370 Free PMC article.
A phase II study of ME2136 (Asenapine Maleate) plus standard antiemetic therapy for patients, including diabetic patients, receiving cisplatin-based chemotherapy.
Hamauchi S, Yasui H, Yokota T, Tsushima T, Fushiki K, Naito T, Ono A, Kado N, Onozawa Y, Murakami H, Takahashi T, Hirashima Y, Mori K, Yamazaki K. Hamauchi S, et al. Among authors: tsushima t. Invest New Drugs. 2024 Dec;42(6):655-663. doi: 10.1007/s10637-024-01480-w. Epub 2024 Oct 26. Invest New Drugs. 2024. PMID: 39460855 Clinical Trial.
ASO Author Reflections: Can Conversion Therapy be an Option for Advanced Esophageal Cancer with Distant Metastases?
Tsuji T, Matsuda S, Sato Y, Tanaka K, Sasaki K, Watanabe M, Hamai Y, Nasu M, Saze Z, Nakashima Y, Nomura M, Yamamoto S, Booka E, Ishiyama K, Bamba T, Sakanaka K, Tsushima T, Takeuchi H, Kato K, Kawakubo H. Tsuji T, et al. Among authors: tsushima t. Ann Surg Oncol. 2025 Jan;32(1):325-326. doi: 10.1245/s10434-024-16310-9. Epub 2024 Oct 1. Ann Surg Oncol. 2025. PMID: 39354244 No abstract available.
Safety and Efficacy of Conversion Therapy After Systemic Chemotherapy in Advanced Esophageal Cancer with Distant Metastases: A Multicenter Retrospective Observational Study.
Tsuji T, Matsuda S, Sato Y, Tanaka K, Sasaki K, Watanabe M, Hamai Y, Nasu M, Saze Z, Nakashima Y, Nomura M, Yamamoto S, Booka E, Ishiyama K, Bamba T, Sakanaka K, Tsushima T, Takeuchi H, Kato K, Kawakubo H. Tsuji T, et al. Among authors: tsushima t. Ann Surg Oncol. 2025 Jan;32(1):274-283. doi: 10.1245/s10434-024-16196-7. Epub 2024 Sep 12. Ann Surg Oncol. 2025. PMID: 39266786
575 results